ARISTOTLE study and sub-group analyses:  Conspicuous points

Aslan, Özgür

Journal Metrics

Impact Factor (2024): 0.9
CiteScore (2023): 1.3
Source Normalized Impact
per Paper:
0.315
SCImago Journal Rank: 0.250

52/8Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and

In titles and abstracts

In keywords

In all

pdf

ARISTOTLE study and sub-group analyses: Conspicuous points [Turk Kardiyol Dern Ars]

Turk Kardiyol Dern Ars. 2016; 44(2): 14-25

ARISTOTLE study and sub-group analyses: Conspicuous points

Özgür Aslan
Dokuz Eylül Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, İzmir

Aristotle study is a phase III study which evaluates apixaban’s safety and efficacy as comparing to warfarin in patients with nonvalvular AF (NVAF) having at least one stroke risk factor of apixaban. 18.201 patients were evaluated in this randomized, controlled, multicentered study. This review will overview of the Aristotle study and subgroup analysis.

Keywords: Aristotle, apixaban, nonvalvular.

Corresponding Author: Özgür Aslan, Türkiye
Manuscript Language: Turkish

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar